To advise of a Serious Shortage Protocol (SSP) in place for paracetamol suppositories 120mg, from 16 February 2023 to 5 May 2023.

This Circular advises NHS Boards and communitypharmacy contractors that eight of the UK-wide SeriousShortage Protocols (SSPs) for Phenoxymethylpenicillinantibiotic products (SSPs 040-047) due to expire on 28February 2023 have been extended until Friday 31March 2023.

This Circular advises that three UK-wide active Serious Shortage Protocols (SSPs) for Hormone Replacement Therapy (HRT) products due to expire on 27 January 2023, have been extended.

This Circular advises that eight of the UK-wide Serious Shortage Protocols (SSPs) for Phenoxymethylpenicillin products (SSPs 040-047) due to expire on 31 January 2023 have been extended until 28 February 2023.

This Circular advises of a Serious Shortage Protocol (SSP) in place for Estradot® (Estradiol) 100 microgram patch, from 25 January 2023 to 17 February 2023.

This Circular advises of a Serious Shortage Protocol (SSP) in place for Estradot® (Estradiol) 50 microgram patch, from 25 January 2023 to 17 February 2023.

This Circular advises NHS Boards and community pharmacy contractors that five of the UK-wide active Serious Shortage Protocols (SSPs) for hormone replacement therapy (HRT) products due to expire on 13 January 2023, have now been extended.

This Circular advises NHS Boards and community pharmacy contractors that five of the UK-wide Serious Shortage Protocols (SSPs) for Phenoxymethylpenicillin products that were issued on 16 December (SSPs 043-047) have been amended to allow pharmacists to supply azithromycin as a further alternative antibiotic. The expiry date for the amended SSPs still remains the 31 January 2023.

To advise of a Serious Shortage Protocol (SSP) in place for Phenoxymethylpenicillin 250mg tablets, from 16 December 2022 to 31 January 2023.

To advise of a Serious Shortage Protocol (SSP) in place for Phenoxymethylpenicillin 250mg/5ml oral solution sugar free, from 16 December 2022 to 31 January 2023.

To advise of a Serious Shortage Protocol (SSP) in place for Phenoxymethylpenicillin 250mg/5ml oral solution, from 16 December 2022 to 31 January 2023.

To advise of a Serious Shortage Protocol (SSP) in place for Phenoxymethylpenicillin 125mg/5ml oral solution sugar free, from 16 December 2022 to 31 January 2023.

To advise of a Serious Shortage Protocol (SSP) in place for Phenoxymethylpenicillin 125mg/5ml oral solution, from 15 December 2022 to 31 January 2023.

To advise of a Serious Shortage Protocol (SSP) in place for Phenoxymethylpenicillin 250mg/5ml oral solution, from 15 December 2022 to 31 January 2023.

To advise of a Serious Shortage Protocol (SSP) in place for Phenoxymethylpenicillin 250mg/5ml oral solution sugar free, from 15 December 2022 to 31 January 2023.

To advise of a Serious Shortage Protocol (SSP) in place for Phenoxymethylpenicillin 125mg/5ml oral solution sugar free, from 15 December 2022 to 31 January 2023.

To advise of a Serious Shortage Protocol (SSP) in place for Estraderm MX® 75 microgram patch, from 15 November 2022 to 13 January 2023.

To advise of a Serious Shortage Protocol (SSP) in place for Estraderm MX® 50 microgram patch, from 15 November 2022 to 13 January 2023.

This Circular advises NHS Boards and community pharmacy contractors that the 12 UK-wide active Serious Shortage Protocols (SSPs) for HRT products due to expire on 28 October 2022, have now been extended.

The Scottish Government have released Circular PAC(P)(2022)29 which advises of an extension to the Serious Shortage Protocol (SSP) in place for Estraderm MX® 100 microgram patch, in place from 8 September, extended to 30 September 2022.